Article thumbnail

Partial Nephrectomy in a Patient with a Left Ventricular Assist Device

By Jules P. Manger, John A. Kern and Tracey L. Krupski

Abstract

Left ventricular assist device (LVAD) use has increased as a bridge to heart transplant as well as destination therapy in patients with severe heart failure. Presence of LVAD is not a contraindication to noncardiac surgery but does present special challenges to the surgical, anesthesia, and cardiac teams. We present the case of a 40-year-old woman with idiopathic cardiomyopathy necessitating LVAD who underwent left partial nephrectomy for a renal mass. She had undergone three nondiagnostic percutaneous image-guided biopsies. Left partial nephrectomy was performed. Perioperative care was without incident due to careful oversight by a multidisciplinary team. Pathology revealed high-grade clear cell renal cell carcinoma (RCC) with negative margins. Polytetrafluoroethylene (PTFE) bolsters were misidentified six months postoperatively on computed tomography (CT) at an outside institution as a retained laparotomy sponge. This is, to our knowledge, the first report of a partial nephrectomy performed in a patient with LVAD

Topics: Case Report
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3350215
Provided by: PubMed Central

Suggested articles

Citations

  1. (2009). A .G arat t i,G .Bru sc hi,T .C olomb oe tal. ,“ N onc ar d iacsu r gic al procedures in patient supported with long-term implantable left ventricular assistdevice,”
  2. (2005). Abdominal wall hernias: imaging features, complications, and diagnostic pitfalls at multi-detector row
  3. (2005). Allaf et al., “Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy,”
  4. (2009). Bacchetta,“Pulmonarylobectomy in a patient with a left ventricular assist device,”
  5. (1999). Cyclosporine induces cancer progression by a cell-autonomous mechanism,”
  6. (2008). efer ,M.M.Desai,A.F ergan y ,A.C.N ovick,andI.S.Gill, “Outcomes of partial nephrectomy in patients onchronic oral anticoagulant therapy,”
  7. (1997). Enhancement of metastasis of prostate adenocarcinoma cells by immune-suppressive cyclosporine
  8. (2009). Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device,”
  9. (1997). I.Penn,“Evaluationoftransplantcandidates withpre-existing malignancies,”
  10. Implanted solid human tumours grow under the renal capsule of cyclosporin- immunosuppressed rats,”
  11. (2008). Low thromboembolic risk for patients with the Heartmate II left ventricular assist device,”
  12. (1995). Noncardiac surgery in long-termimplantableleft ventricular assist-device recipients,”
  13. Occurrence of cancers in immunosuppressed organ transplantrecipients,” Clinical Transplants,
  14. (2005). S h a h ,N .B a k s h i ,K .S .H a f e z ,D .P .W o o dJ r . ,a n dL
  15. (2009). Secure reconstruction technique after partial nephrectomy irrespective of tumor size and location,”
  16. (1995). Use of exogenous material to bolster closure of the parenchymal defect following partial nephrectomy,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.